TERN — Terns Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $294.81m
- $31.37m
- 34
- 31
- 25
- 20
Annual balance sheet for Terns Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19.6 | 74.9 | 166 | 283 | 263 |
| Net Total Receivables | — | 12.7 | 0 | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 22.2 | 90.9 | 167 | 285 | 267 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.961 | 1.18 | 1.05 | 1.8 | 1.03 |
| Other Long Term Assets | |||||
| Total Assets | 23.9 | 92.3 | 168 | 287 | 269 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.95 | 22.8 | 6.82 | 8.47 | 11.9 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 19.7 | 23.7 | 7.77 | 10.1 | 13.2 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.21 | 68.6 | 160 | 277 | 255 |
| Total Liabilities & Shareholders' Equity | 23.9 | 92.3 | 168 | 287 | 269 |
| Total Common Shares Outstanding |